Mohammad Khobreh MSc
Managing Partner, Co-founder
https://www.linkedin.com/in/khobreh/
Mohammad co-leads NG Bio's day-to-day operations and heads the company's fundraising and community efforts to establish meaningful relationships with investors, academics, and, most importantly, patients. In addition, he drives NG Bio's strategy implementation through current and previous investments, including LightOx (oncology), HexagonFab (biosensors) and Cellesce (bioprocessing).
Mohammad is a long-time life science entrepreneur. He is an investor and director at Day Pharma (CDMO) and QMAB (bioprocessing). Further, Mohammad sits on the investment committee of a PE fund with 23 companies under management. Currently, most companies are in the energy and food sector, but Mohammad is leading the expand into the life sciences sector.
Mohammad has a master's degree in Risk Management and Insurance from Bayes Business School of London (formerly Cass) and a bachelor's degree in Management and Manufacturing Engineering from the University of Nottingham.
During his free time, Mohammad is an avid reader. He devours all subjects but particularly enjoys reading about behavioural science, philosophy and macroeconomics. Also, he has just started to play the piano and is looking forward to the arduous yet enjoyable learning journey!
What does Mohammad bring to NG Bio?
Mohammad's curiosity is responsible for a team environment where everyone can and should think, share, and question freely and often. He loves it when the best idea wins but is not afraid to challenge the status quo and pursue lateral, disruptive solutions, even if these fail.